NCCM
CRMD icon

Nine Chapters Capital Management’s CorMedix CRMD Stock Holding History

Nine Chapters Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$22K Buy
+8,480
New +$17.6K 0.05% 149

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Nine Chapters Capital Management's CRMD Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in CorMedix (CRMD) in Q3 2017: 8,480 shares worth $22K. The stake represents 0.05% of the portfolio and ranks #149 among its holdings.

33 funds tracked by Wall St. Rank hold CRMD as of Q3 2017.

  • Nine Chapters Capital Management held 8,480 shares of CorMedix worth $22K as of Q3 2017.
  • CorMedix was a new Nine Chapters Capital Management position in Q3 2017.
  • CorMedix made up 0.05% of Nine Chapters Capital Management's portfolio in Q3 2017, its #149 holding.
  • 33 funds tracked by Wall St. Rank held CorMedix as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.